Osimertinib |
|
Synonyms: N-?[2-?[[2-?(dimethylamino)?ethyl]?methylamino]?-?4-?methoxy-?5-?[[4-?(1-?methyl-?1H-?indol-?3-?yl)?-?2-?pyrimidinyl]?amino]?phenyl]?-2-?Propenamide; AZD 9291 | |
Cat. No.: O77000 | CAS No.: 1421373-65-0 |
MDL.: | Formula: C28H33N7O2 |
F.W.499.61 | Purity: 99% |
Storage: | |
  |

Catalog Number: | O77000 | CAS No.: | 1421373-65-0 | |
MDL: | Formula: | C28H33N7O2 | ||
F.W.: | 499.61 | Purity: | 99% | |
Package: | Unit: | mg | ||
Appearance: | M.P.: | |||
B.P.: | Density: | |||
Optical Rotation: | Refractive Index: | |||
Solubility: | Stability: | |||
Storage: | Category: | Reference Standard | ||
Application: | AZD-9291 is a third-generation EGFR inhibitor, showed promise in preclinical studies and provides hope for patients with advanced lung cancers that have become resistant to existing EGFR inhibitors. |